Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Bionano Genomics, Inc. Common Stock (BNGO)

Laboratory Analytical Instruments

https://bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas.

9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/01/2018

Market Cap

44,984,038

Shares Outstanding

38,840,000

Weighted SO

38,840,337

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ISRG --.--%

LUCY --.--%

STXS --.--%

NXGL --.--%

MBOT --.--%

STAA --.--%

NVST --.--%

GMVD --.--%

BDX --.--%

Beta

2.4140

Last Div

0.0000

Range

0.31-4.2

Chg

0.0065

Avg Vol

1722219

Mkt Cap

44984038

Exch

NASDAQ

Country

US

Phone

858 888 7600

DCF Diff

0.4738

DCF

2.3238

Div Yield

0.0000

P/S

1.2298

EV Multiple

-0.5728

P/FV

0.4402

Div Yield %

0.0000

P/E

-0.1733

PEG

-0.0041

Payout

0.0000

Current Ratio

1.6293

Quick Ratio

1.1054

Cash Ratio

0.5765

DSO

63.4128

DIO

273.5779

Op Cycle

336.9907

DPO

122.6921

CCC

214.2985

Gross Margin

0.2897

Op Margin

-4.9388

Pretax Margin

-5.5795

Net Margin

-5.5798

Eff Tax Rate

-0.0001

ROA

-1.5777

ROE

-2.1583

ROCE

-1.9596

NI/EBT

1.0001

EBT/EBIT

1.1297

EBIT/Rev

-4.9388

Debt Ratio

0.2131

D/E

0.3432

LT Debt/Cap

0.0674

Total Debt/Cap

0.2555

Int Coverage

-35.4854

CF/Debt

-4.0314

Equity Multi

1.6103

Rec Turnover

5.7559

Pay Turnover

2.9749

Inv Turnover

1.3342

FA Turnover

1.1260

Asset Turnover

0.2828

OCF/Share

-1.6446

FCF/Share

-1.6582

Cash/Share

0.4431

OCF/Sales

-3.0385

FCF/OCF

1.0083

CF Coverage

-4.0314

ST Coverage

-5.1069

CapEx Coverage

-120.4182

Div&CapEx Cov

-120.4182

P/BV

0.4402

P/B

0.4402

P/S

1.2298

P/E

-0.1733

P/FCF

-0.4014

P/OCF

-0.3182

P/CF

-0.3182

PEG

-0.0041

P/S

1.2298

EV Multiple

-0.5728

P/FV

0.4402

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 31, 20:26 Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway GlobeNewswire Inc. Dec 26, 08:00 Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping GlobeNewswire Inc. Nov 29, 10:04 Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

Revenue Product Segmentation